SLC1A5 and cancer: Notably, highly expressed SLC1A5 correlated significantly with poor OS in five cancer types, namely bladder (HR = 1.51; 95% CI 1.04, 2.19; p = 0.0315), blood (HR = 1.69; 95% CI 1.05, 2.73; p = 0.0317), brain (HR = 1.96; 95% CI 1.20, 3.19; p = 0.0069), breast (HR = 1.39; 95% CI 1.15, 1.68; p = 5.9e-5), and skin (HR = 3.87; 95% CI 1.34, 11.14; p = 0.0122).